Natarajan Sethuraman – Biography
Last update: 28 days agoExecutive profile
Natarajan was Executive Director and GlycoFi Site Head at Merck, and Director at GlycoFi. Natarajan Sethuraman joined Entrada Therapeutics in 2017. Natarajan served as Chief Scientific Officer at Entrada Therapeutics.
Natarajan Sethuraman is currentlyPresident of Research and Development at Entrada Therapeutics - View - Entrada Therapeutics org chart
Create your alert
to follow the career of Natarajan Sethuraman.
Education
Natarajan Sethuraman has a PhD in Agriculture Operations and Related Sciences from Indian Agricultural Research Institute.
More about Natarajan Sethuraman
Do you need to know more about Natarajan Sethuraman? More results.
Participate
Social media
- Natarajan Sethuraman on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Natarajan Sethuraman
The colleagues of Natarajan Sethuraman
Company Colleagues
- At Entrada Therapeutics, Natarajan Sethuraman has 29 colleagues including Dipal Doshi (CEO), Bernhardt Zeiher (Director)…
Industry Colleagues
- In the Biotechnology industry, Natarajan Sethuraman has 35,756 colleagues in 2,407 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Natarajan Sethuraman.
Get in Touch
Here are a few tips for establishing great contacts.
